Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 5NIH 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Carcinoma, Hepatocellular 11Liver Neoplasms 5Neoplasm Metastasis 3Recurrence 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms 1Lung Metastases 1

Interventions

Sorafenib 42Bevacizumab 26Oxaliplatin 21Radiosurgery 19Gemcitabine 17Fluorouracil 15Hepatectomy 13lenvatinib 12Radiofrequency Ablation 11Nivolumab 11Cisplatin 11Radiotherapy 10Doxorubicin 10Capecitabine 10durvalumab 9Leucovorin 9Blood Specimen Collection 9atezolizumab 8Liver Transplantation 8Everolimus 7Electroporation 7pembrolizumab 6camrelizumab 6Sunitinib 6Immunohistochemistry 6Cryosurgery 6Carboplatin 6tremelimumab 5sintilimab 5apatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Liver Neoplasms × Chemoembolization, Therapeutic × Clear all
NCT06261814 2026-02-17

Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

Thomas Jefferson University

Phase 2 Recruiting
266 enrolled
Gastrointestinal

Liver Neoplasms

NCT03474354 2022-01-06

DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC)

University of Athens

Completed
50 enrolled
Gastrointestinal

Liver Neoplasms

NCT04764409 2021-02-21

PATOC

Central Clinical Hospital RZD-Medicine, Russian Federation

Unknown
500 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis

NCT02470533 2021-01-27

TRENDY

Erasmus Medical Center

Phase 2 Terminated
100 enrolled
Gastrointestinal

Liver Neoplasms

NCT00482586 2015-06-08

Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Vanderbilt University

Completed
137 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡